CD10 Antibody / Neprilysin, Clone: [CDLA10-1], Mouse, Monoclonal

Catalog Number: NSJ-V3870-20UG
Article Name: CD10 Antibody / Neprilysin, Clone: [CDLA10-1], Mouse, Monoclonal
Biozol Catalog Number: NSJ-V3870-20UG
Supplier Catalog Number: V3870-20UG
Alternative Catalog Number: NSJ-V3870-20UG
Manufacturer: NSJ Bioreagents
Host: Mouse
Category: Antikörper
Application: IHC-P, WB
Species Reactivity: Human
Immunogen: A portion of amino acids 297-483 from the human protein was used as the immunogen for the CD10 antibody.
Neprilysin, also known as membrane metallo-endopeptidase (MME), neutral endopeptidase (NEP), cluster of differentiation 10 (CD10), and common acute lymphoblastic leukemia antigen (CALLA) is an enzyme that in humans is encoded by the MME gene. CD10 is a zinc-dependent metalloprotease that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones including glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin. It also degrades the amyloid beta peptide whose abnormal misfolding and aggregation in neural tissue has been implicated as a cause of Alzheimers disease. Synthesized as a membrane-bound protein, the neprilysin ectodomain is released into the extracellular domain after it has been transported from the Golgi apparatus to the cell surface.CD10 is expressed in a wide variety of tissues and is particularly abundant in kidney. It is also a common acute lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of human acute lymphocytic leukemia (ALL). This protein is present on leukemic cells of pre-B phenotype, which represent 85% of cases of ALL. [Wiki]
Clonality: Monoclonal
Clone Designation: [CDLA10-1]
UniProt: P08473
Purity: Protein G affinity chromatography
Form: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Antibody Type: Primary Antibody
Application Dilute: Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT,Western blot: 1-2ug/ml
Application Notes: The stated application concentrations are suggested starting points. Titration of the CD10 antibody may be required due to differences in protocols and secondary/substrate sensitivity.